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125 Feasibility of carrying out spirometry in 3 and 4 year old children
in a standard clinic setting
P. Cole1, F. Hampton1, D. Beeforth1. 1South Tees Hospitals NHS Foundation
Trust, Teesside Cystic Fibrosis Service, Middlesbrough, United Kingdom
Objectives: We used to introduce spirometry to 5 year old (yo) children with the
aim of having reliable results by the age of 6. In 2009 we attempted this with
4yos. In 2011 a 2.5yo girl was keen to copy her 4yo sibling so was allowed to
try spirometry simply to avoid conﬂict. Since she made a reproducible effort we
decided to attempt this in all 3yos.
Methods: Spirometry was carried out in clinic by the physiotherapist who knew
which blowing techniques the children had learned during airway clearance, such
as bubble PEP. A CareFusion MicroLab spirometer was used with the child
incentive. Children aged 3 with good comprehension attempted the test. The parents
understood the potential unreliability of the test. The children were asked to perform
one long blow similar to blowing out birthday candles. The reaction of the incentive
cartoon was explained. The ﬂow-volume loop was checked between blows and
further explanation given if necessary. The best of 3 attempts was recorded.
Results: Some children took a second breath and others did not complete the
blow, particularly after the incentive was met. During successive visits this usually
improved. Overall 9 of 10 3−4yos produced reproducible results, 5 of whom had
useful results at age 3. Several children have had these repeated on multiple clinic
visits showing good lung growth with age.
Conclusion:We have demonstrated that it is feasible during normal appointments to
undertake reproducible spirometry in a signiﬁcant proportion of children as young
as 3. With the new global lung initiative normal ranges extending to younger age
groups we will be able to make an earlier start in following individual trends in
lung function.
126 What factors determine lung function decline in Polish
CF children?
M. Olszowiec-Chlebna1, A. Koniarek-Maniecka1, T. Ruszczyk-Bilecka1,
I. Stelmach1. 1N Copernicus Hospital, Department of Pediatrics and Allergy,
Lodz, Poland
Objectives: It seems that the severity of lung disease in children with cystic ﬁbrosis
(CF) could depend on the type of mutation in the cystic ﬁbrosis transmembrane
conductance regulator gene (CFTR). However, there is wide variability in course
of disease, even among patient presented the same mutation. This fact reﬂects the
inﬂuence of multiple factors such environmental, bacterial colonization and methods
of treatment on the disease.
Aim: To identify risk factors that modify the disease in children suffered from CF.
Methods: The follow-up time was at least 5 years of respiratory status observation
based on FEV1. The socio-economic data, perinatal interview, time of CF diagnosis
and introduction of standard therapy including tobramycin inhalation solution
(TIS), chronic colonization including Pseudomonas aeruginosa (PA) and number
of exacerbations and hospitalizations were assessed.
Results: The mean age of 46 included children was 12.3±7.4 years. Delta F508
homozygous were detected in 42.9%. The most signiﬁcant predictors related to
the decline of FEV1 were PA chronic colonization (OR: 1.01, 95%CI: 1.00–1.02;
p = 0.0165) and late TIS initiation after ﬁrst detection of PA (OR: 1.02, 95%CI:
1.00–1.03; p = 0.0071). A logistic regression analysis conﬁrmed the independence
of other demographic and clinical variables as predisposing factors in lung function
decline.
Conclusion: Our study reviled that chronic PA colonization and late TIS initiation
after ﬁrst detection of PA are at risk of pulmonary decline in CF children. Above
results strongly suggest that in order to be maximally effective, TIS treatment should
begin early after ﬁrst detection of PA.
127 Improving the multiple breath washout test: closed circuit washin
with a novel bolus gas delivery system substantially reduces
washin time and does not alter washout
A. Horsley1,2. 1University of Manchester, Institute of Inﬂammation and Repair,
Manchester, United Kingdom; 2Manchester Adult Cystic Fibrosis Centre,
Manchester, United Kingdom
Objectives: Multiple breath washout (MBW) using the inert tracer gas SF6 is a
sensitive measure of early airway dysfunction in CF. A potential disadvantage of
using an exogenous tracer is the additional time required to wash the SF6 into the
lungs. This report describes a novel bolus washin methodology that substantially
improves washin time.
Methods: All tests were performed sequentially on the same fast-responding
Innocor MBW system. Washin was performed using 0.2% SF6 in an open circuit,
1% SF6 in a rebreathe (closed) circuit and 1% SF6 in a closed circuit using a bolus
technique to deliver all tracer in the ﬁrst part of the ﬁrst inspiration. All tests were
performed in triplicate on healthy controls. A CO2 scrubber was used for closed
circuit tests.
Results: Paired data are available on 10 controls (mean age 36 yrs, 3M, Mean
FEV1 102%). There was no difference in LCI (Mean 6.69, 6.76, 6.68 with open,
closed and bolus closed systems, p = 0.88) or FRC (2.80, 2.79, 2.80 L, p = 0.99)
between washin methods. Washin (analysed to inspired:expired ratio <2%) took
a mean of 34 breaths (163 s) with open circuit vs 13 breaths (61 s) with closed
circuit and 9 breaths (41 s) with bolus washin. Mean end-washin inspired CO2 was
1.6% (closed) and 1.3% (bolus).
Conclusion: Closed circuit washin with an effective CO2 scrubber does not affect
washout endpoints in controls, and results in substantial time savings for test
completion. No additional delay is required between tests. This can be further
improved by using a novel bolus technique to deliver the tracer gas. Testing in
patient groups is ongoing. These developments will allow a much quicker MBW
test using a portable device.
128 Multiple breath nitrogen washout in adults with cystic ﬁbrosis:
a comparison of two commercially available devices
W. Poncin1, A.-S. Aubriot1, P. Lebecque1. 1Cliniques Universitaires Saint-Luc,
University of Louvain, Cystic Fibrosis Unit, Brussels, Belgium
Background: In healthy subjects, multiple breath nitrogen washout (MBWN2)
yields higher LCI values when performed with the Exhalyzer D (Ecomedics,
Switzerland) than when using the EasyOne Pro (NDD, Switzerland).
Objective: To compare data obtained using these devices in CF adults.
Methods: CF patients were studied under stable condition. Before spirometry,
MBWN2 was performed in duplicate with each device, in random order on the same
1H session (10 min to explain the test, 25 min per device). Agreement between
devices was assessed by Bland-Altman plot.
Results: 44 patients (21F; median age: 28.5, IQR 11.5; median FEV1: 76% pr,
IQR: 32%) were investigated. While all patients completed the measurements using
the NDD, 10 (23%, median FEV1: 55% pr) failed to do it within the 25 min
timeframe using EM. Most patients (24/34) expressed a preference towards NDD.
On average, LCI (±SD) EM was consistently higher than LCI NDD (13.73±3.63
vs 10±2.46, p< 0.001; mean difference: 3.72, 95%CI: 4.46 to 2.98), with a clear
bias towards disproportionally higher LCI difference at higher mean values of LCI.
As a consequence, mean duration of each measurement was more than twice longer
with EM (268 s vs 113 s, p< 0.001). Within subjects LCI variability was lower using
EM than using NDD (mean CV ± SD: 5.3% ±4.1) vs 8.5% ±6.5, p = 0.048). The
proportion of patients with normal FEV1 but high LCI was similar with both devices
(p = 0.3).
Conclusion: In CF adults, LCI obtained using current versions of the NDD or
EM are not interchangeable. Measurements with EM are more reproducible, yield
higher LCI values and are signiﬁcantly more time consuming.
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